• Livzon Pharmaceutical will hold an extraordinary general meeting in Zhuhai, Guangdong province, China, on November 12, 2026.
• Shareholders will consider a third-quarter dividend of RMB 12.39 per 10 shares, totaling RMB 1.1 billion, tax inclusive.
• The proposed 2026-2028 return plan targets annual cash distributions of at least 90% of distributable profit and RMB 2 billion in principle.
• Also on the agenda is Zhu Linlin’s appointment as a non-executive director.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Livzon Pharmaceutical Group Inc. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20261023-12380911), on October 23, 2026, and is solely responsible for the information contained therein.